Supriya Lifescience - Quaterly Results

27 May 2025 Evaluate
The company witnessed a 16.39% growth in the revenue at Rs. 1841.09 millions for the quarter ended March 2025 as compared to Rs. 1581.80 millions during the year-ago period.Good  Net Profit growth of 36.42% reported above the corresponding previous quarter figure of Rs. 369.32 millions to Rs. 503.82 millioins.Operating Profit saw a handsome growth to 705.60 millions from 576.90 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1841.09 1581.80 16.39 6964.85 5703.40 22.12 6964.85 5703.40 22.12
Other Income 29.75 21.85 36.16 98.15 106.35 -7.71 98.15 106.35 -7.71
PBIDT 705.60 576.90 22.31 2706.11 1836.10 47.38 2706.11 1836.10 47.38
Interest 4.17 6.01 -30.62 16.86 21.10 -20.09 16.86 21.10 -20.09
PBDT 701.43 570.89 22.87 2689.25 1815.00 48.17 2689.25 1815.00 48.17
Depreciation 60.81 39.14 55.37 204.44 158.11 29.30 204.44 158.11 29.30
PBT 640.62 531.75 20.47 2484.81 1656.89 49.97 2484.81 1656.89 49.97
TAX 136.80 162.43 -15.78 605.23 465.76 29.94 605.23 465.76 29.94
Deferred Tax 9.08 72.99 -87.56 38.66 94.76 -59.20 38.66 94.76 -59.20
PAT 503.82 369.32 36.42 1879.58 1191.13 57.80 1879.58 1191.13 57.80
Equity 160.97 160.97 0.00 160.97 160.97 0.00 160.97 160.97 0.00
PBIDTM(%) 38.33 36.47 5.08 38.85 32.19 20.69 38.85 32.19 20.69

Supriya Lifescience Share Price

745.85 0.95 (0.13%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×